Roland R. Griffiths

Roland Redmond Griffiths (born 1946)[1] is an American psychopharmacologist.[2] He is professor of neuroscience, psychiatry, and behavioral science, and director of the Center for Psychedelic and Consciousness Research at Johns Hopkins University School of Medicine.[3]

"Roland Griffiths" redirects here. For the Australian soldier and author, see Roland Griffiths-Marsh.

Griffiths is credited with helping to revive interest in clinical research with psychedelic drugs in the late 2000s as a potential treatment for addiction, depression, and anxiety.[2][4]

References
  1. Davis, Howland; Kelly, Arthur C.M. (1995). A Livingston Genealogical Register. Kinship. ISBN 9781560121367. Retrieved February 16, 2020.
  2. Wong, Sam (2017). "Reopen your mind". New Scientist. 236 (3153): 28–31. Bibcode:2017NewSc.236...28W. doi:10.1016/S0262-4079(17)32308-4. Retrieved February 15, 2020.
  3. Carey, Benedict (September 4, 2019). "Johns Hopkins Opens New Center for Psychedelic Research". The New York Times. Retrieved February 15, 2020.
  4. Slater, Lauren (April 9, 2018). "Psilocybin Could Help Terminal Patients Face Their Fear of Death". Discover. Retrieved February 15, 2020. In 2006, he published his landmark study, straightforwardly titled 'Psilocybin Can Occasion Mystical-Type Experiences Having Substantial and Sustained Personal Meaning and Spiritual Significance.'

Further reading


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.